Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Investors Hangout MVP's Message Board

$HALB Halberd's PTSD/Alzheimer's R&D Reveals Link

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 99307
(Total Views: 111)
Posted On: 10/20/2021 10:21:58 AM
Avatar
Posted By: louied91
$HALB Halberd's PTSD/Alzheimer's R&D Reveals Link to Potential Obesity Cure

https://www.accesswire.com/668836/halberds-pt...esity-cure

JACKSON CENTER, PA / ACCESSWIRE / October 20, 2021 / Halberd Corporation's (OTC PINK:HALB) ongoing research into discovering treatments/cures for PTSD, Alzheimer's Disease, and other neurodegenerative diseases has led to a potential breakthrough in the battle against obesity. Research has indicated inflammatory cytokines present in the Cerebral Spinal Fluid (CSF) of neurodegenerative disease patients are also found in the blood of those suffering from obesity.

Halberd's patent-pending extracorporeal treatment for removing the disease antigens, excess proteins and cytokines from CSF associated with neurodegenerative diseases can similarly be applied to eliminating the chemical imbalances in blood believed to be responsible for obesity. Removal of these elements from blood would therefore reduce or eliminate the negative health issues associated with obesity, such as high blood pressure, diabetes, heart disease, stroke, cancer, etc. It has been known for several years that obesity is linked to higher risks of death.

Further research is underway with Halberd's university partners.

William A. Hartman, Chairman, President and CEO of Halberd Corporation, stated, "Our plans to pursue cures for PTSD and Alzheimer's Disease involve the removal of select inflammatory cytokines from CSF and blood plasma. We are rapidly pursuing elimination of these target pathogens from CSF and intend to address removal from blood plasma as soon as possible. What is exciting about this development concerning obesity is that our scientists didn't have to initiate any new experimentations, but rather relied on numerous medical articles to affirm our direction."


(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us